T1	intervention 42 52	ultrasound
T2	control 56 67	mammography
T3	ethinicity 124 131	Chinese
T4	location 240 245	China
T6	total-participants 402 408	13 339
T7	eligibility 409 424	high-risk women
T8	age 430 441	30-65 years
T5	outcome 1129 1140	specificity
T9	outcome 1168 1193	positive predictive value
T10	cv-bin-percent 1142 1145	100
T11	iv-bin-percent 1149 1154	99.9%
T12	cv-bin-percent 1195 1199	72.7
T13	iv-bin-percent 1203 1208	70.0%
T14	outcome 974 983	sensitive
T15	iv-bin-percent 985 988	100
T16	cv-bin-percent 992 997	57.1%
T17	outcome 1021 1040	diagnostic accuracy
T18	iv-bin-percent 1042 1047	0.999
T19	cv-bin-percent 1051 1056	0.766
T20	outcome 673 680	cancers
T21	cv-bin-abs 720 721	5
T22	cv-bin-abs 723 727	0.72
T23	control-participants 728 732	1000
T24	iv-bin-abs 765 767	11
T25	cv-bin-abs 769 773	1.51
T26	intervention-participants 774 778	1000
T27	iv-bin-abs 809 811	14
T28	iv-bin-abs 813 817	2.02
T29	intervention-participants 818 822	1000
T30	outcome 910 917	cancers
T31	iv-bin-abs 907 909	14
T32	cv-bin-abs 948 949	8
T33	outcome 1245 1250	costs
T34	iv-cont-mean 1306 1311	$7876
T35	cv-cont-mean 1313 1320	$45 253
T36	iv-cont-mean 1326 1333	$21 599
